NIH-funded research R21 grant

Developing a vaccine to create protective immune cells against Salmonella infections

Official title: Vaccine induction of Salmonella-specific Th1 memory cells

Funded at University of California at Davis · NIH-11031610 · Data updated 2026-11-12

This study is looking at how a new vaccine can help your immune system fight off Salmonella infections by boosting special immune cells, and it will also test a new way to deliver the vaccine that might make it work even better.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California at Davis
NIH-funded
Lab location1 site (Davis, United States)
Project startSeptember 26, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$225,839
NIH project number1R21AI187632-01
Project IDNIH-11031610 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children under the age of 11 who are at risk for Salmonella infections.

Less likely to help

Patients who are older than 11 years or those who have already been vaccinated against Salmonella may not benefit from this research.

What this research studies

This research focuses on understanding how a vaccine can effectively induce specific immune cells known as Th1 memory cells to protect against Salmonella infections. The study will investigate the role of IL-18R expression in these immune cells and their location in the liver, which may enhance their protective capabilities. Additionally, the researchers will explore the use of an innovative mRNA nanoparticle delivery system to improve the vaccine's effectiveness in generating these protective immune responses.

Why it matters

Potential benefit: If successful, this research could lead to a more effective vaccine that provides better protection against Salmonella infections in children.

How similar studies have gone: Previous research has shown promising results in using mRNA technology for vaccine development, indicating potential success for this approach.

Where this research is happening

  • University of California at Davis
    Davis, United States
    Active

Researchers

  • Principal investigator: Mcsorley, Stephen J — University of California at Davis
  • Study coordinator: Mcsorley, Stephen J

Related research

Other NIH-funded projects on the same topics.

  • UC Davis IGA Innovation Center

    A research center at UC Davis will study gene-edited livestock to improve animal health, safety, and policy through sharing genetic data and findings about genome edits in cattle, pigs, sheep, and goats.

    NIH research University of California at Davis · Davis, United States · NIH-11641870

  • Administrative Core of an equitable breast cancer screening program

    A national program headed from UC Davis is coordinating several research efforts to improve how breast cancer screening is done in community settings.

    NIH research University of California at Davis · Davis, United States · NIH-11622111

  • The role of novelty and surprise in learning for people with Alzheimer’s disease

    A study explores how surprising events affect memory and learning in people related to Alzheimer’s disease, using everyday tasks to see how the brain remembers new information.

    NIH research University of California at Davis · Davis, United States · NIH-11617755

  • Understanding how distraction affects students and how to measure it better

    This grant studies why distracted students, including those with ADHD, struggle in real-life learning and tests a clearer way to measure distraction in everyday settings.

    NIH research University of California at Davis · Davis, United States · NIH-11617018

  • California Partnership for Personalized Nutrition

    A California clinical center is testing personalized dietary approaches to improve blood sugar and health for adults with diabetes by using big data and AI to tailor meals.

    NIH research University of California at Davis · Davis, United States · NIH-11605720

  • Advancing gastric cancer care for Latinos through patient-derived tumor models

    Aimed at Latinos with gastric cancer, this project uses patient-derived tumor models to study how cancer biology and treatments work in real tumors.

    NIH research University of California at Davis · Davis, United States · NIH-11603175

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.